# Northland Nuclear Medicine, LLC – FDA Inspection, Jun 7, 2019

Source: https://www.keypedia.com/records/fda_inspections/northland-nuclear-medicine-llc/1d9a3582-f77c-4de9-b9c2-80c2cd2bbb27
Source feed: FDA_Inspections

> FDA inspection 1092563 of Northland Nuclear Medicine, LLC, June 07, 2019. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 212. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1092563
- Company Name: Northland Nuclear Medicine, LLC
- Inspection Date: 2019-06-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Minneapolis District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 1210014 - 2023-07-13](https://www.keypedia.com/records/fda_inspections/northland-nuclear-medicine-llc/b625c27f-5639-4afc-a90f-39876f36f744)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/anthony-j-ladner/dbb6b53a-80d1-4b47-ae42-6eb2053dfa4b)
- [Scott A. Golladay](https://www.keypedia.com/people/scott-a-golladay/78c90066-7212-4442-900c-5cdcb677aeec)

Company: https://www.keypedia.com/companies/northland-nuclear-medicine-llc/ea5b0f88-b6c0-4949-ad0d-aaa0d0e6fbd4

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d